feed,title,long_url,short_url
Motley,Has Sarepta Therapeutics Become a No-Brainer Stock Buy After This Recent FDA News?,https://www.fool.com/investing/2024/07/04/sarepta-therapeutics-no-brainer-stock-buy-fda/?source=iedfolrf0000001,https://da.gd/gdW41K
Motley,"With Its New CEO On Board, Is It Time to Reassess Investing in This Household Robot Maker?",https://www.fool.com/investing/2024/07/04/with-its-new-ceo-on-board-is-it-time-to-reassess/?source=iedfolrf0000001,https://da.gd/CYUX3
